Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sener, A; Bessieres, B; Courtois, P; Ladriere, L; Louchami, K; Jijakli, H; Malaisse, WJ
   Uptake of 1-deoxy-1-[I-125]iodo-D-mannoheptulose by different cell types: In vitro and in vivo experiments
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   A. Sener et al., "Uptake of 1-deoxy-1-[I-125]iodo-D-mannoheptulose by different cell types: In vitro and in vivo experiments", INT J MOL M, 7(5), 2001, pp. 495-500
2. Creutzfeldt, W
   The entero-insular axis in type 2 diabetes - incretins as therapeutic agents
   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
   
   W. Creutzfeldt, "The entero-insular axis in type 2 diabetes - incretins as therapeutic agents", EXP CL E D, 109, 2001, pp. S288-S303
3. Malaisse, WJ
   On the track to the beta-cell
   DIABETOLOGIA
   
   W.J. Malaisse, "On the track to the beta-cell", DIABETOLOG, 44(4), 2001, pp. 393-406
4. Leclercq-Meyer, V; Kadiata, MM; Malaisse, WJ
   Effects of D-mannoheptulose and its hexaacetate ester on hormonal secretion from the perfused pancreas
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   V. Leclercq-Meyer et al., "Effects of D-mannoheptulose and its hexaacetate ester on hormonal secretion from the perfused pancreas", INT J MOL M, 6(2), 2000, pp. 143-152
5. Cancelas, J; Acitores, A; Villanueva-Penacarrillo, ML; Malaisse, WJ; Valverde, I
   Activation of glycogen synthase a in hepatocytes exposed to alpha-D-glucose pentaacetate
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   J. Cancelas et al., "Activation of glycogen synthase a in hepatocytes exposed to alpha-D-glucose pentaacetate", INT J MOL M, 6(2), 2000, pp. 197-199
6. Ladriere, L; Kadiata, MM; Verbruggen, I; Willem, R; Malaisse, WJ
   Metabolism of D-[1,2-C-13]glucose and alpha-D-[1,2-C-13]glucose pentaacetate in tumoral pancreatic islet cells
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   L. Ladriere et al., "Metabolism of D-[1,2-C-13]glucose and alpha-D-[1,2-C-13]glucose pentaacetate in tumoral pancreatic islet cells", INT J MOL M, 5(4), 2000, pp. 331-333
7. Nauck, M; Hahn, S; Sauerwald, A; Schmiegel, W
   Lack of germline mutations in the preproglucagon gene region coding for glucagon-like peptide 1 in Type 2 diabetic (NIDDM) patients
   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
   
   M. Nauck et al., "Lack of germline mutations in the preproglucagon gene region coding for glucagon-like peptide 1 in Type 2 diabetic (NIDDM) patients", EXP CL E D, 108(2), 2000, pp. 72-75
8. Sorbera, LA; Leeson, PA; Castaner, RM; Castaner, J
   Mitiglinide calcium hydrate - Antidiabetic
   DRUGS OF THE FUTURE
   
   L.A. Sorbera et al., "Mitiglinide calcium hydrate - Antidiabetic", DRUG FUTURE, 25(10), 2000, pp. 1034-1042
9. Jijakli, H; Malaisse, WJ
   Effect of D-mannoheptulose upon the cationic and secretory responses to alpha-D-glucose pentaacetate in perifused rat pancreatic islets
   ENDOCRINE
   
   H. Jijakli e W.J. Malaisse, "Effect of D-mannoheptulose upon the cationic and secretory responses to alpha-D-glucose pentaacetate in perifused rat pancreatic islets", ENDOCRINE, 10(3), 1999, pp. 219-224
10. Kadiata, MM; Laghmich, A; Nadi, AB; Malaisse, WJ
    Isomeric and anomeric specificity of the metabolic and secretory response of rat pancreatic islets to glucose pentaacetate
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    M.M. Kadiata et al., "Isomeric and anomeric specificity of the metabolic and secretory response of rat pancreatic islets to glucose pentaacetate", INT J MOL M, 3(6), 1999, pp. 573-575
11. Ladriere, L; Bjorkling, F; Malaisse, WJ
    Assessment of the nutritional value of glycerol-1,2,3-tris(methylsuccinate) in fed and starved rats
    MOLECULAR GENETICS AND METABOLISM
    
    L. Ladriere et al., "Assessment of the nutritional value of glycerol-1,2,3-tris(methylsuccinate) in fed and starved rats", MOL GEN MET, 67(3), 1999, pp. 254-260
12. Malaisse, WJ; Dard-Brunelle, B
    Binding of tritiated S21403 to an artificial phospholipid bilayer
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
    
    W.J. Malaisse e B. Dard-Brunelle, "Binding of tritiated S21403 to an artificial phospholipid bilayer", RES COM M P, 103(3), 1999, pp. 269-274
13. Giroix, MH; Scruel, O; Ladriere, L; Sener, A; Portha, B; Malaisse, WJ
    Metabolic and secretory interactions between D-glucose and D-fructose in islets from GK rats
    ENDOCRINOLOGY
    
    M.H. Giroix et al., "Metabolic and secretory interactions between D-glucose and D-fructose in islets from GK rats", ENDOCRINOL, 140(12), 1999, pp. 5556-5565
14. Fernandez, J; Valdeolmillos, M
    Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic beta-cells recorded in vivo
    DIABETES
    
    J. Fernandez e M. Valdeolmillos, "Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic beta-cells recorded in vivo", DIABETES, 48(4), 1999, pp. 754-757
15. Mercan, D; Kadiata, MM; Malaisse, WJ
    Differences in the time course of the metabolic response of B and non-B pancreatic islet cells to D-glucose and metabolized or non-metabolized hexoseesters
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    D. Mercan et al., "Differences in the time course of the metabolic response of B and non-B pancreatic islet cells to D-glucose and metabolized or non-metabolized hexoseesters", BIOC BIOP R, 262(2), 1999, pp. 346-349
16. ROSSELIN G; LECLERCQMEYER V; BOISSART C; PESSAH M; MALAISSE WJ
    GLP-1 RECEPTORS IN GOLDEN SYRIAN-HAMSTER ISLETS - IDENTIFICATION AND FUNCTIONAL-CHARACTERIZATION
    ENDOCRINE
    
    G. Rosselin et al., "GLP-1 RECEPTORS IN GOLDEN SYRIAN-HAMSTER ISLETS - IDENTIFICATION AND FUNCTIONAL-CHARACTERIZATION", ENDOCRINE, 8(3), 1998, pp. 323-330
17. MALAISSE WJ
    MONOSACCHARIDE ESTERS - NEW TOOLS IN BIOMEDICAL-RESEARCH
    Molecular genetics and metabolism ( Molecular genetics and metabolism (Print))
    
    W.J. Malaisse, "MONOSACCHARIDE ESTERS - NEW TOOLS IN BIOMEDICAL-RESEARCH", Molecular genetics and metabolism ( Molecular genetics and metabolism (Print)), 65(2), 1998, pp. 129-142
18. KIMURA I; SASAMURA T; TSUNEKI H; IWAI M; FURUTA I; SASAMOTO H; FURUSAWA Y
    IMMUNOCYTOCHEMICAL LOCALIZATION OF SALIVARY PEPTIDE P-C IN HUMAN SUBMANDIBULAR-GLAND
    Biological & pharmaceutical bulletin
    
    I. Kimura et al., "IMMUNOCYTOCHEMICAL LOCALIZATION OF SALIVARY PEPTIDE P-C IN HUMAN SUBMANDIBULAR-GLAND", Biological & pharmaceutical bulletin, 21(5), 1998, pp. 506-512
19. NAITO H; SASAKI I; MATSUNO S
    SURGICAL ASPECT OF ENTEROINSULAR AXIS AFTER GASTROINTESTINAL SURGERY WITH REFERENCE TO INCRETIN SECRETION
    Pancreas
    
    H. Naito et al., "SURGICAL ASPECT OF ENTEROINSULAR AXIS AFTER GASTROINTESTINAL SURGERY WITH REFERENCE TO INCRETIN SECRETION", Pancreas, 16(3), 1998, pp. 370-378
20. BRUBAKER PL; EFENDIC S; GREENBERG GR
    TRUNCATED AND FULL-LENGTH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) DIFFERENTIALLY STIMULATE INTESTINAL SOMATOSTATIN RELEASE
    Endocrine
    
    P.L. Brubaker et al., "TRUNCATED AND FULL-LENGTH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) DIFFERENTIALLY STIMULATE INTESTINAL SOMATOSTATIN RELEASE", Endocrine, 6(1), 1997, pp. 91-95
21. JIJAKLI H; ULUSOY S; MALAISSE WJ
    DYNAMICS OF THE CATIONIC AND SECRETORY RESPONSES TO A-4166 IN PERIFUSED PANCREATIC-ISLETS
    Fundamental and clinical pharmacology
    
    H. Jijakli et al., "DYNAMICS OF THE CATIONIC AND SECRETORY RESPONSES TO A-4166 IN PERIFUSED PANCREATIC-ISLETS", Fundamental and clinical pharmacology, 11(4), 1997, pp. 300-304
22. BALKS HJ; HOLST JJ; VONZURMUHLEN A; BRABANT G
    RAPID OSCILLATIONS IN PLASMA GLUCAGON-LIKE PEPTIDE-1 (GLP-1) IN HUMANS - CHOLINERGIC CONTROL OF GLP-1 SECRETION VIA MUSCARINIC RECEPTORS
    The Journal of clinical endocrinology and metabolism
    
    H.J. Balks et al., "RAPID OSCILLATIONS IN PLASMA GLUCAGON-LIKE PEPTIDE-1 (GLP-1) IN HUMANS - CHOLINERGIC CONTROL OF GLP-1 SECRETION VIA MUSCARINIC RECEPTORS", The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 786-790
23. MONTROSERAFIZADEH C; YANG H; WANG YH; ROTH J; MONTROSE MH; ADAMS LG
    NOVEL SIGNAL-TRANSDUCTION AND PEPTIDE SPECIFICITY OF GLUCAGON-LIKE PEPTIDE RECEPTOR IN 3T3-L1 ADIPOCYTES
    Journal of cellular physiology
    
    C. Montroserafizadeh et al., "NOVEL SIGNAL-TRANSDUCTION AND PEPTIDE SPECIFICITY OF GLUCAGON-LIKE PEPTIDE RECEPTOR IN 3T3-L1 ADIPOCYTES", Journal of cellular physiology, 172(3), 1997, pp. 275-283
24. LINS L; BRASSEUR R; MALAISSE WJ
    PHARMACOLOGY OF THE HYPOGLYCEMIC SULFONYLUREA GLIQUIDONE .3. CONFORMATIONAL-ANALYSIS
    Pharmacological research
    
    L. Lins et al., "PHARMACOLOGY OF THE HYPOGLYCEMIC SULFONYLUREA GLIQUIDONE .3. CONFORMATIONAL-ANALYSIS", Pharmacological research, 34(1-2), 1996, pp. 9-10
25. NADI AB; ZHANG TM
    EFFECTS OF THE METHYL-ESTERS OF PYRUVATE, SUCCINATE AND GLUTAMATE ON THE SECRETORY RESPONSE TO MEGLITINIDE ANALOGS IN RAT PANCREATIC-ISLETS
    Pharmacological research
    
    A.B. Nadi e T.M. Zhang, "EFFECTS OF THE METHYL-ESTERS OF PYRUVATE, SUCCINATE AND GLUTAMATE ON THE SECRETORY RESPONSE TO MEGLITINIDE ANALOGS IN RAT PANCREATIC-ISLETS", Pharmacological research, 33(3), 1996, pp. 191-194
26. MALAISSELAGAE F; MALAISSE WJ
    FATE OF H-3-LABELED AND C-14-LABELED A-4166 IN PANCREATIC-ISLETS
    Acta diabetologica
    
    F. Malaisselagae e W.J. Malaisse, "FATE OF H-3-LABELED AND C-14-LABELED A-4166 IN PANCREATIC-ISLETS", Acta diabetologica, 33(4), 1996, pp. 298-300
27. MALAISSE WJ
    REGULATION, PERTURBATION, AND CORRECTION OF METABOLIC EVENTS IN PANCREATIC-ISLETS
    Acta diabetologica
    
    W.J. Malaisse, "REGULATION, PERTURBATION, AND CORRECTION OF METABOLIC EVENTS IN PANCREATIC-ISLETS", Acta diabetologica, 33(3), 1996, pp. 173-179
28. CREUTZFELDT WOC; ORSKOV C; KLEINE N; HOLST JJ; WILLMS B; NAUCK MA
    GLUCAGONOSTATIC ACTIONS AND REDUCTION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE I(7-36) AMIDE IN TYPE-I DIABETIC-PATIENTS
    Diabetes care
    
    W.O.C. Creutzfeldt et al., "GLUCAGONOSTATIC ACTIONS AND REDUCTION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE I(7-36) AMIDE IN TYPE-I DIABETIC-PATIENTS", Diabetes care, 19(6), 1996, pp. 580-586
29. DALESSIO DA; VOGEL R; PRIGEON R; LASCHANSKY E; KOERKER D; ENG J; ENSINCK JW
    ELIMINATION OF THE ACTION OF GLUCAGON-LIKE PEPTIDE-1 CAUSES AN IMPAIRMENT OF GLUCOSE-TOLERANCE AFTER NUTRIENT INGESTION BY HEALTHY BABOONS
    The Journal of clinical investigation
    
    D.A. Dalessio et al., "ELIMINATION OF THE ACTION OF GLUCAGON-LIKE PEPTIDE-1 CAUSES AN IMPAIRMENT OF GLUCOSE-TOLERANCE AFTER NUTRIENT INGESTION BY HEALTHY BABOONS", The Journal of clinical investigation, 97(1), 1996, pp. 133-138
30. HUANG THJ; BRUBAKER PL
    SYNTHESIS AND SECRETION OF GLUCAGON-LIKE PEPTIDE-1 BY FETAL-RAT INTESTINAL-CELLS IN CULTURE
    Endocrine
    
    T.H.J. Huang e P.L. Brubaker, "SYNTHESIS AND SECRETION OF GLUCAGON-LIKE PEPTIDE-1 BY FETAL-RAT INTESTINAL-CELLS IN CULTURE", Endocrine, 3(7), 1995, pp. 499-503
31. GOKE B; GOKE R; FEHMANN HC; ARNOLD R
    INCRETIN RESEARCH ON THE DEVELOPMENT OF N EW STRATEGIES FOR DIABETES THERAPY
    Der Internist
    
    B. Goke et al., "INCRETIN RESEARCH ON THE DEVELOPMENT OF N EW STRATEGIES FOR DIABETES THERAPY", Der Internist, 36(4), 1995, pp. 343-349
32. FEHMANN HC; GOKE B
    GLUCAGON-LIKE PEPTIDE .1. A POSSIBLE ALTE RNATIVE IN THE TREATMENT OFDIABETES-MELLITUS
    Deutsche Medizinische Wochenschrift
    
    H.C. Fehmann e B. Goke, "GLUCAGON-LIKE PEPTIDE .1. A POSSIBLE ALTE RNATIVE IN THE TREATMENT OFDIABETES-MELLITUS", Deutsche Medizinische Wochenschrift, 119(8), 1994, pp. 275-279